Evidence map›Paper›PMID 27695918›Full record

ArticleEuropean journal of clinical pharmacology2017

Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence.

Lucie Blais, Fatima-Zohra Kettani, Amélie Forget, Marie-France Beauchesne, Catherine Lemière, Francine M Ducharme

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Global Initiative for Asthma report: How will new recommendations affect practice in Canada?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2020
    Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lucie BlaisFaculté de Pharmacie, Université de Montréal, Montréal, QC, Canada. lucie.blais@umontreal.ca.ORCID http://orcid.org/0000-0001-8420-3128
Fatima-Zohra KettaniFaculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.
Amélie ForgetFaculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.
Marie-France BeauchesneFaculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.
Catherine LemièreFaculté de Pharmacie, Université de Montréal, Montréal, QC, Canada.
Francine M DucharmeClinical Research and Knowledge Transfer Unit on Childhood Asthma, Research Centre, CHU Sainte-Justine, Montreal, Canada.
Hôpital du Sacré-Cœur de Montréal · CACentre Hospitalier Universitaire de Sherbrooke · CACentre Hospitalier Universitaire Sainte-Justine · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere are very few studies on primary adherence (i.e., first filling of a prescription) to inhaled corticosteroids (ICS) in asthma patients; two have involved children. Moreover, adherence can be overestimated when considering only secondary adherence (i.e., following the medication recommendations for a defined period) and ignoring primary adherence. We aimed thus to evaluate the real-world primary and secondary adherence to ICS and to develop an integrated primary and secondary adherence (IPSA) measure.

methodsFrom two clinical databases of pediatric and adult asthma patients, we included 198 children and 206 adults with one ICS prescription recorded in their medical chart between 2010 and 2012 and follow-up data for ≥12 months. Adherence was estimated from written prescriptions and prescription claims data. Primary adherence was defined as filling the ICS prescription at a pharmacy within 12 months. Secondary adherence was defined as the proportion of days covered (PDC) in subjects who filled their prescription at least once. The IPSA was based on the PDC with a correction factor for primary adherence.

resultsPrimary adherence to ICS at 12 months was 89.4 % in children and 69.4 % in adults. Secondary adherence at 12 months in children was 33.9 %, and the IPSA was 30.3 %. These values were 52.8 and 36.6 %, respectively, in adults.

conclusionsPrimary adherence to ICS is low in adults and secondary adherence is poor in children and adults. Using the PDC as a unique measure of adherence led to significant overestimation in adults; IPSA leads to more valid estimates of adherence to ICS.

Indexed as

Drug MonitoringAdministration, InhalationAdolescentAdrenal Cortex HormonesAdultAnti-Asthmatic AgentsAsthmaChildChild, PreschoolCohort StudiesDatabases, FactualDrug PrescriptionsFemaleHumansInfantInfant, NewbornAdrenal Cortex HormonesAnti-Asthmatic AgentsAdministrative databasesAsthmaInhaled corticosteroidsPrimary adherenceSecondary adherenceWritten prescriptions

Identifiers

PMID27695918
OpenAlexW2526264022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.